Glucocorticoid-induced autophagy in osteocytes

Abstract

Glucocorticoid (GC) therapy is the most frequent cause of secondary osteoporosis. In this study we have demonstrated that GC treatment induced the development of autophagy, preserving osteocyte viability. GC treatment resulted in an increase in autophagy markers and the accumulation of autophagosome vacuoles in vitro and in vivo promoted the onset of the osteocyte autophagy, as determined by expression of autophagy markers in an animal model of GC-induced osteoporosis. An autophagy inhibitor reversed the protective effects of GCs. The effects of GCs on osteocytes were in contrast to tumor necrosis factor α (TNF-α), which induced apoptosis but not autophagy. Together this study reveals a novel mechanism for the effect of GC on osteocytes, shedding new insight into mechanisms responsible for bone loss in patients receiving GC therapy. © 2010 American Society for Bone and Mineral Research.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 30

1. 1.

   Weinstein R, Rosen CJ. Glucocorticoid-induced osteoporosis. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 2008.

   Not in our library

2. 2.

   Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Ann NY Acad Sci. 2002;966:73-81.

   Not in our library10.1111/j.1749-6632.2002.tb04204.x

3. 3.

   Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest. 1998;102:274-282.

   Not in our library10.1172/jci2799

4. 4.

   O'Brien CA, Jia D, Plotkin LI, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004;145:1835-1841.

   Not in our library10.1210/en.2003-0990

5. 5.

   Gohel A, McCarthy MB, Gronowicz G. Estrogen prevents glucocorticoid-induced apopotosis in osteoblasts in vivo and in vitro. Endocrinology. 1999;140:5339-5347.

   Not in our library10.1210/endo.140.11.7135

6. 6.

   Jilka RL, Weinstein RS, Parfitt AM, Manolagas SC. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res. 2007;22:1492-1501.

   Not in our library10.1359/jbmr.070518

7. 7.

   Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15:993-1000.

   Not in our library10.1359/jbmr.2000.15.6.993

8. 8.

   Lane NE, Yao W, Balooch M, et al. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Min Res. 2006;21:466-476.

   Not in our library10.1359/jbmr.051103

9. 9.

   Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069-1075.

   Not in our library10.1038/nature06639

10. 10.

    Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nature Rev. 2007;8:741-752.

    Not in our library10.1038/nrm2239

11. 11.

    Gurusamy N, Das DK. Is autophagy a double-edged sword for the heart? Acta Physiol. Hung. 2009;96:267-276.

    Not in our library10.1556/aphysiol.96.2009.3.2

12. 12.

    Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death Differentiation. 2005;12:1528-1534.

    Not in our library10.1038/sj.cdd.4401777

13. 13.

    Cherian PP, Siller-Jackson AJ, Gu S, et al. Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. Mol Biol Cell. 2005;16:3100-3106.

    Not in our library10.1091/mbc.e04-10-0912

14. 14.

    Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways. Mole Pharmacol. 2007;72:29-39.

    Not in our library10.1124/mol.106.033167

15. 15.

    Mao J, Regelson W, Kalimi M. Molecular mechanism of RU 486 action: a review. Mol Cell Biochem. 1992;109:1-8.

    Not in our library10.1007/bf00230867

16. 16.

    Horwitz KB. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer. Endocr Rev. 1992;13:146-163.

    Not in our library10.1210/edrv-13-2-146

17. 17.

    Yang J, Shah R, Robling AG, et al. HMGB1 is a bone-active cytokine. J Cell Physiol. 2007;214:730-739.

    Not in our library10.1002/jcp.21268

18. 18.

    Valamanesh F, Torriglia A, Savoldelli M, et al. Glucocorticoids induce retinal toxicity through mechanism mainly associated with paraptosis. Mole Vis. 2007;13:1746-1757.

    Not in our library

19. 19.

    Hunter AL, Choy JC, Granville DJ. Detection of apoptosis in cardiovascular diseases. Methods Mol Med. 2005;112:277-289.

    Not in our library10.1385/1-59259-879-x:277

20. 20.

    Klionsky D, Abeliovich H, Agostinis P, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008;4:151-175.

    Not in our library10.4161/auto.5338

21. 21.

    Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homogogue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720-5728.

    Not in our library10.1093/emboj/19.21.5720

22. 22.

    Kim J, Klionsky DJ. Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells. Annu Rev Biochem. 2000;69:303-342.

    Not in our library10.1146/annurev.biochem.69.1.303

23. 23.

    Biederbick A, Kern HF, Elsässer HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 1995;66:3-14.

    Not in our library

24. 24.

    Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy. 2007;3:542-545.

    Not in our library10.4161/auto.4600

25. 25.

    Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differentiation. 2004;11:448-457.

    Not in our library10.1038/sj.cdd.4401359

26. 26.

    Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mole Biol Cell. 2004;15:1101-1111.

    Not in our library10.1091/mbc.e03-09-0704

27. 27.

    Conradie MM, de Wet H, Kotze DDR, Hough FS, Hulley PA. Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo. J Endocrinol. 2007;195:229-240.

    Not in our library10.1677/joe-07-0217

28. 28.

    Gu G, Hentunen TA, Nars M, Harkonen PL, Vaananen HK. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis. 2005;10:583-595.

    Not in our library10.1007/s10495-005-1893-0

29. 29.

    Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, Lane NE. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum. 2008;58:1674-1686.

    Not in our library10.1002/art.23454

30. 30.

    Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999;104:1363-1374.

    Not in our library10.1172/jci6800

Cited by papers we hold 3

• Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis · 2021
  No notice
• BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects · 2021
  No notice
• The amazing osteocyte · 2010
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.